Last reviewed · How we verify
NCT05452395
Post-acute Care for Patients With Frailty
NA trial testing Post-acute care in Frailty in 254 participants. Completed in 31 December 2020.
31 December 2020
Quick facts
| Lead sponsor | Taipei City Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 254 |
| Start date | 19 June 2020 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Post-acute care
Conditions studied
- Frailty — all drugs for Frailty →
- Retrospective Study — all drugs for Retrospective Study →
Sponsor
Taipei City Hospital
Who can join
75 and older, any sex, with Frailty or Retrospective Study. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Acute illness could be enormous stress for frail people. Combining comprehensive geriatric assessment and multifactorial intervention has positive effects on frail community older adults. However, few studies investigated the effects of post-acute care (PAC) in frail older patients who just recovered from acute hospitalization. This study aimed to evaluate the effects of PAC on frail older adults in Taiwan.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Post-acute care for frail older people decreases 90-day emergency room visits, readmissions and mortality: An interventional study.
Lee MC, Wu TY, Huang SJ, Chen YM, et al · · 2023 · cited 8× · PMID 36607971 · DOI 10.1371/journal.pone.0279654
Verify or expand the search:
- PubMed search for NCT05452395
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Frailty
Currently open trials in the same condition.
- NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
- NCT07519603 — Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program · NA · recruiting
- NCT07144527 — Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults · NA · recruiting
- NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home · NA · recruiting
- NCT07475767 — Ultrasound Indicators of Nutritional Status and Treatment Outcomes in Surgical Patients in the Intensive Care Unit · recruiting
Other Taipei City Hospital trials
Trials by the same sponsor.
- NCT06337214 — TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy · NA · recruiting
- NCT07501546 — Enhancing Childhood Obesity Interventions Through Digital Media Tools · NA · completed
- NCT06139276 — Outcomes of Frozen Shoulder Treated With Small Needle-Knife Through Microcirculation and Pulse Analysis. · NA · unknown
- NCT06100198 — The Effect of Nutrition and Exercise Program on the Health of Community-dwelling Older Adults · NA · unknown
- NCT07105761 — Body-Mind-Spirit Action Group on the Well-being · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05452395 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei City Hospital
- Last refreshed: 11 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05452395.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing